Patient beliefs and behaviors about genomic risk for type 2 diabetes: Implications for prevention

dc.contributor.author

Gallagher, Patrick

dc.contributor.author

King, Heather A

dc.contributor.author

Haga, Susanne B

dc.contributor.author

Orlando, Lori A

dc.contributor.author

Joy, Scott V

dc.contributor.author

Trujillo, Gloria M

dc.contributor.author

Scott, William Michael

dc.contributor.author

Bembe, Marylou

dc.contributor.author

Creighton, Dana L

dc.contributor.author

Cho, Alex H

dc.contributor.author

Ginsburg, Geoffrey S

dc.contributor.author

Vorderstrasse, Allison

dc.date.accessioned

2016-01-11T15:27:18Z

dc.date.issued

2015-01-01

dc.description.abstract

Copyright © Taylor & Francis Group, LLC 2015.Type 2 diabetes is a major health burden in the United States, and population trends suggest this burden will increase. High interest in, and increased availability of, testing for genetic risk of type 2 diabetes presents a new opportunity for reducing type 2 diabetes risk for many patients; however, to date, there is little evidence that genetic testing positively affects type 2 diabetes prevention. Genetic information may not fit patients illness representations, which may reduce the chances of risk-reducing behavior changes. The present study aimed to examine illness representations in a clinical sample who are at risk for type 2 diabetes and interested in genetic testing. The authors used the Common Sense Model to analyze survey responses of 409 patients with type 2 diabetes risk factors. Patients were interested in genetic testing for type 2 diabetes risk and believed in its importance. Most patients believed that genetic factors are important to developing type 2 diabetes (67%), that diet and exercise are effective in preventing type 2 diabetes (95%), and that lifestyle changes are more effective than drugs (86%). Belief in genetic causality was not related to poorer self-reported health behaviors. These results suggest that patients interest in genetic testing for type 2 diabetes might produce a teachable moment that clinicians can use to counsel behavior change.

dc.identifier.eissn

1087-0415

dc.identifier.issn

1081-0730

dc.identifier.uri

https://hdl.handle.net/10161/11501

dc.publisher

Taylor and Francis Inc.

dc.relation.ispartof

Journal of Health Communication

dc.relation.isversionof

10.1080/10810730.2015.1018563

dc.title

Patient beliefs and behaviors about genomic risk for type 2 diabetes: Implications for prevention

dc.type

Journal article

duke.contributor.orcid

Haga, Susanne B|0000-0001-8817-7406

duke.contributor.orcid

Orlando, Lori A|0000-0003-2534-7855

duke.contributor.orcid

Ginsburg, Geoffrey S|0000-0003-4739-9808

pubs.begin-page

728

pubs.end-page

735

pubs.issue

6

pubs.organisational-group

Biomedical Engineering

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Initiatives

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Cardiology

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Pratt School of Engineering

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

Sanford School of Public Policy - Secondary Group

pubs.organisational-group

School of Medicine

pubs.organisational-group

School of Nursing

pubs.organisational-group

School of Nursing - Secondary Group

pubs.publication-status

Published

pubs.volume

20

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
T2D attitudes.pdf
Size:
116.76 KB
Format:
Adobe Portable Document Format